 |
|
|
|
|
|
|
|
|
"Through internal capabilities and strategic partnerships, we will utilize the best available research and development platforms to develop innovative therapies and pioneering product advances."
— Larry Stern, Chairman and CEO, Talecris Biotherapeutics
Scientific and technical innovation has been a cornerstone of our business since the earliest efforts to develop biological therapeutics from human plasma in the 1940's. Sixty years later, Talecris continues to lead the industry in research and applications in pathogen safety, developing products to improve the quality and convenience of patients' lives, and supporting external programs that increase scientific knowledge.
At Talecris Biotherapeutics, our award-winning research and development teams focus their efforts on the discovery of new protein therapies, the development of advanced manufacturing technologies, and innovative virus removal and inactivation techniques. In addition our scientists remain focused on continuous improvement to the safety, efficacy, and reliability of Talecris' existing products.
|
|
|
|
|
|
|
|
